ResearcherJiangsu Province HospitalNo recent work listed

Feng Zhu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-0831-4923; OpenAlex author ID A5015347657. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 8

Papers, trials and grants by year

2020: 2 papers

Papers 2

Glycolysis promotes the progression of pancreatic cancer and reduces cancer cell sensitivity to gemcitabine. Co-author DOI 10.1016/j.biopha.2019.109521 ↗
EFNB2 facilitates cell proliferation, migration, and invasion in pancreatic ductal adenocarcinoma via the p53/p21 pathway and EMT. Co-author DOI 10.1016/j.biopha.2020.109972 ↗

Closest collaborators

The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Dalai Xu · 2 shared papers, 2020 · strength 0.22
- Paper EFNB2 facilitates cell proliferation, migration, and invasion in pancreatic ductal adenocarcinoma via the p53/p21 pathw… DOI 10.1016/j.biopha.2020.109972 ↗
- Paper Glycolysis promotes the progression of pancreatic cancer and reduces cancer cell sensitivity to gemcitabine. DOI 10.1016/j.biopha.2019.109521 ↗
Yi Miao · 2 shared papers, 2020 · strength 0.22
- Paper EFNB2 facilitates cell proliferation, migration, and invasion in pancreatic ductal adenocarcinoma via the p53/p21 pathw… DOI 10.1016/j.biopha.2020.109972 ↗
- Paper Glycolysis promotes the progression of pancreatic cancer and reduces cancer cell sensitivity to gemcitabine. DOI 10.1016/j.biopha.2019.109521 ↗
Junli Wu · 2 shared papers, 2020 · strength 0.22
- Paper EFNB2 facilitates cell proliferation, migration, and invasion in pancreatic ductal adenocarcinoma via the p53/p21 pathw… DOI 10.1016/j.biopha.2020.109972 ↗
- Paper Glycolysis promotes the progression of pancreatic cancer and reduces cancer cell sensitivity to gemcitabine. DOI 10.1016/j.biopha.2019.109521 ↗
Shangnan Dai · 2 shared papers, 2020 · strength 0.22
- Paper EFNB2 facilitates cell proliferation, migration, and invasion in pancreatic ductal adenocarcinoma via the p53/p21 pathw… DOI 10.1016/j.biopha.2020.109972 ↗
- Paper Glycolysis promotes the progression of pancreatic cancer and reduces cancer cell sensitivity to gemcitabine. DOI 10.1016/j.biopha.2019.109521 ↗
Xiaole Zhu · 1 shared paper, 2020 · strength 0.10
- Paper Glycolysis promotes the progression of pancreatic cancer and reduces cancer cell sensitivity to gemcitabine. DOI 10.1016/j.biopha.2019.109521 ↗
Yunpeng Peng · 1 shared paper, 2020 · strength 0.10
- Paper Glycolysis promotes the progression of pancreatic cancer and reduces cancer cell sensitivity to gemcitabine. DOI 10.1016/j.biopha.2019.109521 ↗
Yi Zhu · 1 shared paper, 2020 · strength 0.10
- Paper Glycolysis promotes the progression of pancreatic cancer and reduces cancer cell sensitivity to gemcitabine. DOI 10.1016/j.biopha.2019.109521 ↗
Qiuyang Chen · 1 shared paper, 2020 · strength 0.10
- Paper Glycolysis promotes the progression of pancreatic cancer and reduces cancer cell sensitivity to gemcitabine. DOI 10.1016/j.biopha.2019.109521 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.